<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23-antibodies-08-00023">
 <label>23.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Soriani</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Petit</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Grifantini</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Petracca</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Gancitano</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Frigimelica</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Nardelli</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Garcia</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Spinelli</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Scarabelli</surname>
    <given-names>G.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Exploiting antigenic diversity for vaccine design: The chlamydia ArtJ paradigm</article-title>
  <source>J. Biol. Chem.</source>
  <year>2010</year>
  <volume>285</volume>
  <fpage>30126</fpage>
  <lpage>30138</lpage>
  <pub-id pub-id-type="doi">10.1074/jbc.M110.118513</pub-id>
  <pub-id pub-id-type="pmid">20592031</pub-id>
 </element-citation>
</ref>
